U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX6895237: GSM4094598: CD4_siNS_isotype_rep3; Homo sapiens; RNA-Seq
1 ILLUMINA (Illumina HiSeq 3000) run: 40.3M spots, 6.1G bases, 2.3Gb downloads

Submitted by: NCBI (GEO)
Study: CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance
show Abstracthide Abstract
Transcriptome profiling and functional analyses on expanding Tcons revealed that FOXP3 enhances expression of the SLAM family receptor CD48, which in turn sustains basal autophagy and suppresses pro-apoptotic p53 signaling. Our findings suggest that FOXP3 governs a distinct transcriptional program in early-stage effector Tcons that maintains RICD resistance via CD48-dependent protective autophagy and p53 suppression. Overall design: Purified human CD4 T cells were electroporated with siRNAs against CD48 or negative-control medum GC duplex siRNA and differential gene expression analysis was performed using mRNA sequencing.
Sample: CD4_siNS_isotype_rep3
SAMN12830320 • SRS5428082 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: Illumina HiSeq 3000
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: Total RNA was isolated from primary T cells using the Qiagen RNeasy Plus Mini Kit with on-column DNase digestion. Total RNA integrity was assessed using automated capillary electrophoresis on a AATI Fragment Analyzer. The integrity of all samples are RQI > 8.0 A minimum starting amount of 75 ng was used as input for library preparation using the Illumina TruSeq Stranded mRNA Library Preparation Kit
Experiment attributes:
GEO Accession: GSM4094598
Links:
Runs: 1 run, 40.3M spots, 6.1G bases, 2.3Gb
Run# of Spots# of BasesSizePublished
SRR1017373340,289,4076.1G2.3Gb2019-12-16

ID:
9072581

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...